TNFRSF14 and Miyoshi myopathy: As shown in Fig. 3A, CD112, CD137L, CD275, CD270, and GAL9 were expressed at significantly higher rates in the CD34+ MM cell fraction compared to the CD34− MM cell fraction (P < 0.01).